Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Consulting agrmnt
Director departure
Asset disposition
Auditor change
Acq. announced
Appointed director
Filed Chapter 11
Aspira Women's Health Inc. (VRML) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/14/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/24/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
06/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT"
05/11/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ASPIRA WOMEN’S HEALTH INC."
05/11/2023 8-K Quarterly results
Docs: "Exhibit 99.1 First Quarter total product revenue of $2.3 million, an increase of 26% year-over-year First Quarter OvaSuite volume of 6,259 units, an increase of 29% year-over-year"
05/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/28/2023 8-K Preliminary quarterly results
03/30/2023 8-K Quarterly results
03/22/2023 8-K Quarterly results
Docs: "Exhibit 99.1"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT"
02/10/2023 8-K Quarterly results
02/07/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ASPIRA WOMEN’S HEALTH INC."
01/10/2023 8-K Investor presentation
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Achievement of Cash Utilization Guidance, and Other Highlights Preliminary fourth quarter 2022 volume was 5,643 tests, an increase of 18% compared to last year"
12/21/2022 8-K Quarterly results
12/02/2022 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
08/24/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and between Aspira Women’s Health Inc. and William Blair & Company, L.L.C",
"Form of Warrant",
"Opinion of Sidley Austin LLP"
08/10/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/23/2022 8-K Quarterly results
Docs: "Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration"
02/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Bylaws of Aspira Women’s Health Inc., effective February 23, 2022",
"Amended and Restated Employment Agreement between Aspira Women’s Health Inc. and Valerie B. Palmieri effective March 1, 2022",
"Employment Agreement between Aspira Women’s Health Inc. and Nicole Sandford effective March 1, 2022",
"Aspira Women’ s Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy